fda glp-1 safety warning september 2025 drugs like semaglutide and tirzepatide have surged in popularity for diabetes and weight loss — now used by about 1 in 8 U.S. adults and known to protect the heart. ⁠ ⁠ GLP-1 Genetics: How Genes Affect

Impact on Non-Motor Symptoms GLP-1 RAs have shown encouraging potential in addressing non-motor symptoms in PD, which are major contributors to disability and reduced quality of Life

Expanding access for Medicare-aged adults: Access to GLP-1 therapies for Medicare-aged adults is a growing area of research, especially as the obesity epidemic impacts older populations

: The effect of green tea supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials Ying Lin et al

( E and F ) Feature plots for identified Reactome pathways ( E ) positively and ( F ) negatively correlated with VSMC Glp1r KO